About CytoTronics
CytoTronics is a company based in Boston (United States) founded in 2015 by Vince Wu. CytoTronics has raised $22.75 million across 2 funding rounds from investors including Anzu Partners and Milad Alucozai. The company has 22 employees as of December 31, 2024. CytoTronics offers products and services including Pixel and Cloud-Based Software. CytoTronics operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, DiscoverX and Saguaro, among others.
- Headquarter Boston, United States
- Employees 22 as on 31 Dec, 2024
- Founders Vince Wu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytotronics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.75 M (USD)
in 2 rounds
-
Latest Funding Round
$13.5 M (USD), Series A
Mar 22, 2024
-
Investors
Anzu Partners
& 1 more
-
Employee Count
22
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CytoTronics
CytoTronics offers a comprehensive portfolio of products and services, including Pixel and Cloud-Based Software.
Enables monitoring of live-cell functions for biological research applications.
Facilitates quick analysis of live-cell measurements for cellular insights.
People of CytoTronics
Unlock access to complete
Unlock access to complete
Funding Insights of CytoTronics
CytoTronics has successfully raised a total of $22.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13.5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CytoTronics
CytoTronics has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Anzu Partners and Milad Alucozai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in industrial and life sciences technology companies.
|
Locked | Locked | Locked | |
|
MA
Milad Alucozai |
-
|
Locked | Locked | Locked |
Investor details for CytoTronics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CytoTronics
Investment portfolio details for CytoTronics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CytoTronics
Detailed financials for CytoTronics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytotronics Comparisons
Peer comparison for CytoTronics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CytoTronics
CytoTronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, DiscoverX and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
Detailed competitors of CytoTronics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytotronics
Complete news archive for CytoTronics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CytoTronics
CytoTronics was founded in 2015 and raised its 1st funding round 7 years after it was founded.
CytoTronics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
CytoTronics is a funded company, having raised a total of $22.75M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at CytoTronics is 22.
CytoTronics was founded in 2015 in Boston, United States, and operates in the biotechnology sector focused on drug discovery. Cell-based assays are enabled through a CMOS electronics platform, which measures and manipulates live cells for real-time, high-resolution electrical and electrochemical analysis. Optics-free imaging is facilitated, supporting applications in pharmaceutical research and development.
CytoTronics's top competitors include Kiyatec, Remedy Plan and Indigo Biosciences.
CytoTronics offers Pixel and Cloud-Based Software.
CytoTronics has 2 investors. Key investors include Anzu Partners, and Milad Alucozai.